Pd-Rx Pharmaceutical Company Insiders

Pd-Rx Pharmaceutical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0556 % which means that it generated a profit of $0.0556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2457 %, meaning that it created $0.2457 on every $100 dollars invested by stockholders. Pd-Rx Pharmaceutical's management efficiency ratios could be used to measure how well Pd-Rx Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. Some institutional investors establish a significant position in pink sheets such as Pd-Rx Pharmaceutical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pd-Rx Pharmaceutical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Pd-Rx Pharmaceutical Workforce Comparison

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.

Pd Rx Pharmaceutical Benchmark Summation

Pd-Rx Pharmaceutical Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Pd Rx Pharmaceutical often depends on how effective the management is. Pd-Rx Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pd-Rx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pd-Rx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Pd-Rx Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Pd Rx Pharmaceutical. Check Pd-Rx Pharmaceutical's Beneish M Score to see the likelihood of Pd-Rx Pharmaceutical's management manipulating its earnings.

When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.